reports
Groupe Parot: 1 director
A director at Groupe Parot maiden bought 4,984,436 shares at 8.830EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Greenworks (Jiangsu) Co Ltd: 1 director
A director at Greenworks (Jiangsu) Co Ltd bought 300,000 shares at 15.200CNY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
Shandong Dongyue Organosilicon Materials Co Ltd: 1 director
A director at Shandong Dongyue Organosilicon Materials Co Ltd bought 50,000 shares at 7.850CNY and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...
Zhejiang Narada Power Source Co Ltd: 3 directors
Three Directors at Zhejiang Narada Power Source Co Ltd bought/maiden bought 59,800 shares at between 10.370CNY and 10.380CNY. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by...
Jiangxi Fushine Pharmaceutical Co Ltd: 1 director
A director at Jiangxi Fushine Pharmaceutical Co Ltd bought 604,700 shares at 10.360CNY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
Silynxcom and 3M PELTOR Further Collaborate for Latest Innovative Solu...
Silynxcom and 3M PELTOR Further Collaborate for Latest Innovative Solution, the ComTac™ VIII Headset Netanya, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices as well as other communication accessories, announced the expansion of its ongoing collaboration with 3M™ PELTOR™ ("Peltor"). Peltor is recognized as a global leading manufacturer of over-the-ear headsets. Known for its commitment to innovation and quality, Peltor's products are designe...
Alliance Trust PLC - Net Asset Value
Alliance Trust PLC - Net Asset Value ALLIANCE TRUST PLC At the close of business Friday 03 May 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was - excluding income, 1254.6p - including income, 1261.1p The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was - excluding income, 1259.4p - including income, 1265.9p For further information, please contact: - Juniper Partners LimitedTel. +44 (0)131 378 0500 Notes Net Asset Values are calculated in acc...
EQS-News: Mainz Biomed präsentiert Ergebnisse der Darmkrebsfrüherkennu...
Emittent / Herausgeber: Mainz BioMed N.V. / Schlagwort(e): Konferenz Mainz Biomed präsentiert Ergebnisse der Darmkrebsfrüherkennungsstudie eAArly DETECT auf der Digestive Disease Week 2024 07.05.2024 / 14:01 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Mainz Biomed präsentiert Ergebnisse der Darmkrebsfrüherkennungsstudie eAArly DETECT auf der Digestive Disease Week 2024 Die Studiendaten von eAArly DETECT belegten eine Sensitivität für Darmkrebs von 97% mit einer Spezifität von 97% und eine Sensitivität für fortgeschrittene Adenom...
EQS-News: Mainz Biomed to Present Results of Colorectal Cancer Screeni...
Issuer: Mainz BioMed N.V. / Key word(s): Conference Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. 07.05.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity for advanced adenoma of 82% BERKELE...
EQS-News: Mynaric selected by Rocket Lab for Space Development Agency’...
EQS-News: Mynaric AG / Key word(s): Incoming Orders Mynaric selected by Rocket Lab for Space Development Agency’s Tranche 2 Transport Layer – Beta Program 07.05.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Laser Communications Manufacturer Expands Customer Roster LOS ANGELES, May 7, 2024 – (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, today announced that it has been selected by Rocket Lab USA, Inc (NASDAQ: RKLB) to supply free space optical ...
EQS-News: Mynaric wurde von Rocket Lab für das Tranche 2 Transport Lay...
EQS-News: Mynaric AG / Schlagwort(e): Auftragseingänge Mynaric wurde von Rocket Lab für das Tranche 2 Transport Layer - Beta Programm der Space Development Agency ausgewählt 07.05.2024 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Hersteller für Laserkommunikation erweitert Kundenstamm LOS ANGELES, 7. Mai 2024 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), ein führender Großserienanbieter von kosteneffektiven und in skalierbaren Mengen produzierten Laserkommunikationsprodukten, gab heute bekannt, dass es von Rocket Lab USA, Inc. (...
Hitachi Energy supports long-term operation of largest HVDC-connected ...
Hitachi Energy supports long-term operation of largest HVDC-connected wind energy project in U.S. Multi-year agreement provides service solutions to the SunZia Transmission Project, linking New Mexico’s wind farms to Arizona’s grid, increasing renewable energy to Western States Zurich, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Hitachi Energy announced that it has signed a multi-year agreement with Pattern Energy to support its high-voltage direct current (HVDC) technologies for the SunZia Transmission Project. The link will connect the 3,515-megawatt (MW) SunZia Wind project in New ...
Interim report for Q2 and H1 2023/24 (the period 01.10.2023 - 31.03.20...
Interim report for Q2 and H1 2023/24 (the period 01.10.2023 - 31.03.2024) Nørresundby, Denmark, 7 May 2024Announcement no. 25/2024 Q2 MEETS EXPECTATIONS, WITH GROWING ORDERS AND SALES, IN A MARKET, WHERE CUSTOMER INVENTORIES ARE NORMALIZING AND REORDERING IS BEGINNING TO PICK UP. “The results for Q2 are in line with our expectations for the quarter, reaching sales of DKK 125 million and trimming inventory by DKK 8 million during the quarter. In Q2, we furthermore see an increase in our order intake, indicating a shift towards more typical market dynamics, characterized by shorter ...
- Roelof-Jan van den Akker
Technical Analysis/Cocoa
The daily chart worsened significantly last week, violating our bullish view we communicated in the previous updates in combination with the bullish target for US$13,265/MT. This suggests that prices have topped within the accelerating move since the breakout above US$4,275/MT mid-January.
Bridger Aerospace Announces Schedule for its First Quarter 2024 Earnin...
Bridger Aerospace Announces Schedule for its First Quarter 2024 Earnings Release and Conference Call BELGRADE, Mont., May 07, 2024 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today announced that it will release financial results for the first quarter ended March 31, 2024 on Monday, May 13, 2024 after the market close. Management will conduct an investor conference call on Monday, May 13, 2024, at 5:00 p.m. Eastern Time (3:00 p.m. Mountain Time) to discus...
Form 8.3 - UK Commercial Property REIT Limited
Form 8.3 - UK Commercial Property REIT Limited 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securitie...
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® ...
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that additional data supporting IBSRELA® (tenapanor) will be presented at the 2024 Digestive Disease Week Conference (DDW), to be held May 18-2...
Mainz Biomed to Present Results of Colorectal Cancer Screening Study e...
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity for advanced adenoma of 82% BERKELEY, Calif. and MAINZ, Germany, May 07, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, will present an analysis from its eAArly DETECT study at Digestive Disease Week (DDW) 2024 in Washington D.C. from May ...
Zscaler Joins Forces with Google to Offer Unparalleled Zero Trust Data...
Zscaler Joins Forces with Google to Offer Unparalleled Zero Trust Data and Threat Protection Enterprises can now Ensure Secure, Remote Access to Private Web Apps across devices and locations with Zscaler and Google Chrome Enterprise SAN JOSE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ZS), the leader in cloud security, has collaborated with Google on a joint zero trust architecture with Chrome Enterprise. This powerful combination brings the power of Zscaler Private Access™ (ZPA) enabling zero trust secure access to private applications to anyone across different locations and d...
Great Lakes Reports First Quarter 2024 Results
Great Lakes Reports First Quarter 2024 Results First quarter net income of $21.0 millionFirst quarter adjusted EBITDA of $42.9 millionDredging backlog of $879.4 million at March 31, 2024 HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (Nasdaq: GLDD), the largest provider of dredging services in the United States, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Revenue was $198.7 millionTotal operating profit was $31.5 millionNet income was $21.0 millionAdjusted ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.